跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,159 条关于
“MIDD”
全部
8,159
临床试验
7,059
药物
42
机构
56
资讯
1,002
4个月前
Certara Divests Regulatory and Medical Writing Business to Veristat for $135 Million to Focus on AI-Driven Drug Development
去年
UWM-Developed Drug, GL-Damonia, Enters FDA Phase 1 Trials for Depression and Alzheimer's
9个月前
NetraMark Secures Phase 3 Contract Following FDA Milestone for AI-Powered Clinical Trial Platform
2年前
Asciminib's Flexible Dosing: Daily Regimen Shows Comparable Efficacy and Safety in CML
4个月前
Altasciences and Certara Form Strategic Partnership to Accelerate Early-Phase Drug Development
上个月
OMEICOS' OMT-28 Heads Directly to Pivotal Phase 3 in Primary Mitochondrial Diseases Following FDA Endorsement
去年
Certara's Simcyp Simulator Becomes First PBPK Modeling Platform to Receive EMA Qualification for EU Regulatory Submissions
去年
Mito Fund Invests in Khondrion to Advance Sonlicromanol for Primary Mitochondrial Disease
去年
Certara Appoints AI Pioneer Dr. Chris Bouton as CTO to Advance Next-Generation Drug Development Platform
8天前
Penn Medicine Receives $50 Million Gift to Fund Early-Stage Cancer, Autoimmune and Infectious Disease Research
第 1 页,共 101 页
上一页
下一页